New study tracks muscle decline in rare disease to guide future treatments
NCT ID NCT03842878
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study followed 52 people with limb-girdle muscular dystrophy 2I (LGMD2I) for up to two years to learn more about how the disease changes over time. Researchers measured walking ability, muscle strength, heart function, and daily activities. The goal was to better understand the disease's natural course, which can help design future treatment trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LGMD2I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr Tanya Stojkovic
Paris, 75013, France
-
Pr John Vissing
Copenhagen, DK-2100, Denmark
-
Pr Volker Straub
Newcastle, NE1 3BZ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.